Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial.
Porras C, Romero B, Kemp T, Fantin R, Herrero R, Hildesheim A, Ocampo R, Sierra MS, Gail MH, Schussler J, Schiller JT, Lowy DR, Pinto LA, Liu D, Kreimer AR; Costa Rica HPV Vaccine Trial Study Group. Porras C, et al. Among authors: liu d. J Natl Cancer Inst Monogr. 2024 Nov 1;2024(67):329-336. doi: 10.1093/jncimonographs/lgae032. J Natl Cancer Inst Monogr. 2024. PMID: 39529529 Free PMC article. Clinical Trial.
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial.
Shing JZ, Porras C, Pinheiro M, Herrero R, Hildesheim A, Liu D, Gail MH, Romero B, Schiller JT, Zúñiga M, Mishra S, Burdette L, Jones K, Schussler J, Ocampo R, Fang J, Liu Z, Lowy DR, Tsang SH, Rodríguez AC, Schiffman M, Haas CB, Carvajal LJ, Brown JR, Kreimer AR, Mirabello L; Costa Rica HPV Vaccine Trial (CVT) Group. Shing JZ, et al. Among authors: liu z, liu d. NPJ Vaccines. 2024 Jun 8;9(1):101. doi: 10.1038/s41541-024-00896-y. NPJ Vaccines. 2024. PMID: 38851816 Free PMC article.
Online registry of neonatal necrotising enterocolitis in Shenzhen: protocol for a multicentre, prospective, open, observational cohort study.
Guo X, Feng J, Zhao X, Ying E, Liu D, Tu H, Yan Y, Huang H, Li X, Chen X, Zeng S, Lin Y, Zhou K, Zhang L, Yuan S, Zhang Q, Lin F, Dou L, Chai Y, Cai Y, Liu R, Bai L, Chen T, Chen Z, Wang Z, Li Y, Gong X, Fang X, Zhang A, Li G, Liao Z, Chen C, Chen J, Guo Y, Liu Y, Tang H, Lin H, Rao DD. Guo X, et al. Among authors: liu d. BMJ Open. 2024 Nov 24;14(11):e091290. doi: 10.1136/bmjopen-2024-091290. BMJ Open. 2024. PMID: 39581716 Free article.
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Nov 21:S0140-6736(24)01762-8. doi: 10.1016/S0140-6736(24)01762-8. Online ahead of print. Lancet. 2024. PMID: 39581202
38,035 results
You have reached the last available page of results. Please see the User Guide for more information.